Premium
High normal post‐load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children
Author(s) -
Di Bonito Procolo,
Licenziati Maria Rosaria,
Baroni Marco Giorgio,
Congiu Tiziana,
Incani Michela,
Iannuzzi Arcangelo,
Maffeis Claudio,
Perrone Laura,
Valerio Giuliana,
Del Giudice Emanuele Miraglia
Publication year - 2014
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.20787
Subject(s) - medicine , insulin resistance , endocrinology , impaired glucose tolerance , triglyceride , blood pressure , cohort , overweight , prediabetes , nonalcoholic fatty liver disease , metabolic syndrome , insulin , type 2 diabetes , gastroenterology , obesity , diabetes mellitus , fatty liver , disease , cholesterol
Objective To evaluate normoglycemic overweight/obese (Ow/Ob) children whose post‐load plasma glucose (2hPG) cut‐point may be significantly associated with cardiometabolic risk factors (CMRFs) and whether this cut‐point predicts preclinical signs of organ damage. Methods One thousand seven hundred and thrity four normoglycemic Ow/Ob children were stratified into quintiles of 2hPG, the sixth group was constituted by 101 children with impaired glucose tolerance (IGT). Results Moving from the lower quintiles of 2hPG to IGT, the groups differed for Prepubertal stage, BMI, fasting PG, insulin levels, blood pressure, and lipids. To evaluate the best cut‐off of 2hPG related to CMRFs, the area under the receiver operating characteristic curve and the Youden's index was calculated. Insulin resistance, high blood pressure, and high triglyceride/HDL‐C ratio were associated with a 2hPG cut‐off of 110 mg/dl. Children with 2hPG ≥110 mg/dl showed 1.3‐3.2 fold higher risk to have high levels of ALT (as surrogate of nonalcoholic fatty liver disease) or increased carotid intima‐media thickness. Conclusions This study, performed in a large cohort of Ow/Ob children, shows that an atherogenic risk profile and preclinical signs of organ damage are associated with post‐challenge elevations in plasma glucose still considered in the high normal range.